PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.05%
Revenue decline while 3088.T shows 1.48% growth. Joel Greenblatt would examine competitive position erosion.
-3.89%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-4.70%
Gross profit decline while 3088.T shows 4.91% growth. Joel Greenblatt would examine competitive position.
-0.67%
Margin decline while 3088.T shows 3.38% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.49%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
1.19%
Operating expenses growth less than half of 3088.T's 2.88%. David Dodd would verify sustainability.
-3.07%
Total costs reduction while 3088.T shows 0.74% growth. Joel Greenblatt would examine advantage.
7.69%
Similar interest expense growth to 3088.T's 7.69%. Walter Schloss would investigate norms.
5.66%
D&A growth 1.25-1.5x 3088.T's 4.05%. Martin Whitman would scrutinize asset base.
-12.60%
EBITDA decline while 3088.T shows 1.52% growth. Joel Greenblatt would examine position.
-8.90%
EBITDA margin decline while 3088.T shows 0.04% growth. Joel Greenblatt would examine position.
-24.93%
Operating income decline while 3088.T shows 14.59% growth. Joel Greenblatt would examine position.
-21.76%
Operating margin decline while 3088.T shows 12.92% growth. Joel Greenblatt would examine position.
52.21%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
-19.43%
Pre-tax income decline while 3088.T shows 0.87% growth. Joel Greenblatt would examine position.
-16.02%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-18.46%
Tax expense reduction while 3088.T shows 7.29% growth. Joel Greenblatt would examine advantage.
-19.88%
Both companies show declining income. Martin Whitman would check industry conditions.
-16.49%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-19.88%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-19.88%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-0.00%
Share count reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.